BR9710250A - Composto composição farmacêutica e processos para tratar uma infecção bacteriana em um paciente em necessidade de tal tratamento e para produzir um composto de bromotiacumicina - Google Patents

Composto composição farmacêutica e processos para tratar uma infecção bacteriana em um paciente em necessidade de tal tratamento e para produzir um composto de bromotiacumicina

Info

Publication number
BR9710250A
BR9710250A BR9710250A BR9710250A BR9710250A BR 9710250 A BR9710250 A BR 9710250A BR 9710250 A BR9710250 A BR 9710250A BR 9710250 A BR9710250 A BR 9710250A BR 9710250 A BR9710250 A BR 9710250A
Authority
BR
Brazil
Prior art keywords
compound
bromothiacumycin
patient
treating
processes
Prior art date
Application number
BR9710250A
Other languages
English (en)
Inventor
Jill E Hochlowski
Marianna Jackson
James B Mcalpine
Ronald R Rasmussen
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of BR9710250A publication Critical patent/BR9710250A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9710250A 1996-07-12 1997-06-24 Composto composição farmacêutica e processos para tratar uma infecção bacteriana em um paciente em necessidade de tal tratamento e para produzir um composto de bromotiacumicina BR9710250A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/678,906 US5767096A (en) 1996-07-12 1996-07-12 Bromotiacumicin compounds
PCT/US1997/011064 WO1998002447A1 (en) 1996-07-12 1997-06-24 Bromotiacumicin compounds

Publications (1)

Publication Number Publication Date
BR9710250A true BR9710250A (pt) 1999-08-10

Family

ID=24724791

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9710250A BR9710250A (pt) 1996-07-12 1997-06-24 Composto composição farmacêutica e processos para tratar uma infecção bacteriana em um paciente em necessidade de tal tratamento e para produzir um composto de bromotiacumicina

Country Status (20)

Country Link
US (1) US5767096A (pt)
EP (1) EP0923594B1 (pt)
JP (1) JP2000515512A (pt)
KR (1) KR100476799B1 (pt)
CN (1) CN1149220C (pt)
AR (1) AR007854A1 (pt)
AT (1) ATE225364T1 (pt)
AU (1) AU730839B2 (pt)
BR (1) BR9710250A (pt)
CA (1) CA2257984A1 (pt)
CZ (1) CZ294843B6 (pt)
DE (1) DE69716094T2 (pt)
DK (1) DK0923594T3 (pt)
ES (1) ES2186900T3 (pt)
HU (1) HU224966B1 (pt)
IL (1) IL127540A (pt)
NZ (1) NZ333258A (pt)
PT (1) PT923594E (pt)
WO (1) WO1998002447A1 (pt)
ZA (1) ZA975861B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005534332A (ja) * 2002-07-29 2005-11-17 オプティマー ファーマシューティカルズ、インコーポレイテッド チアクマイシン生産
US20070105791A1 (en) * 2002-07-29 2007-05-10 Optimer Pharmaceuticals, Inc. Method of treating clostridium difficile-associated diarrhea
US7906489B2 (en) * 2004-05-14 2011-03-15 Optimer Pharmaceuticals, Inc. 18-membered macrocycles and analogs thereof
ES2395404T3 (es) * 2004-05-14 2013-02-12 Optimer Pharmaceuticals, Inc. Tratamiento de las enfermedades asociadas al uso de antibióticos
US7378508B2 (en) * 2007-01-22 2008-05-27 Optimer Pharmaceuticals, Inc. Polymorphic crystalline forms of tiacumicin B
BRPI0519890A2 (pt) * 2005-01-31 2009-03-31 Optimer Pharmaceuticals Inc macrociclos de 18 elementos e seus análogos
TWI523654B (zh) 2007-11-27 2016-03-01 默沙東藥廠 抗生素巨環化合物以及其製造及使用之方法
CN102115757B (zh) * 2010-12-14 2015-10-28 中国科学院南海海洋研究所 台勾霉素的生物合成基因簇及其应用
JO3464B1 (ar) 2013-01-15 2020-07-05 Astellas Pharma Europe Ltd التركيبات الخاصة بمركبات التياكوميسين
IN2013MU00711A (pt) * 2013-03-08 2015-06-26 Cipla Ltd
TR201815891T4 (tr) 2014-05-09 2018-11-21 Astellas Pharma Europe Ltd Tiakumisin bileşiği için tedavi rejimi.
US10548912B2 (en) 2015-07-03 2020-02-04 Astellas Pharma Europe Ltd. Dosage regimen for a tiacumicin compound

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4918174A (en) * 1986-09-26 1990-04-17 Abbott Laboratories Tiacumicin compounds

Also Published As

Publication number Publication date
EP0923594A1 (en) 1999-06-23
CZ294843B6 (cs) 2005-03-16
KR20000023662A (ko) 2000-04-25
DE69716094D1 (de) 2002-11-07
AU730839B2 (en) 2001-03-15
KR100476799B1 (ko) 2005-03-16
EP0923594B1 (en) 2002-10-02
AR007854A1 (es) 1999-11-24
ZA975861B (en) 1998-01-30
HUP9903902A3 (en) 2001-06-28
CA2257984A1 (en) 1998-01-22
AU3504697A (en) 1998-02-09
WO1998002447A1 (en) 1998-01-22
CN1225096A (zh) 1999-08-04
HU224966B1 (en) 2006-04-28
DK0923594T3 (da) 2003-02-10
JP2000515512A (ja) 2000-11-21
DE69716094T2 (de) 2003-06-05
HUP9903902A2 (hu) 2001-05-28
US5767096A (en) 1998-06-16
NZ333258A (en) 2000-07-28
CN1149220C (zh) 2004-05-12
ES2186900T3 (es) 2003-05-16
PT923594E (pt) 2003-02-28
ATE225364T1 (de) 2002-10-15
CZ2899A3 (cs) 1999-03-17
IL127540A0 (en) 1999-10-28
IL127540A (en) 2004-05-12

Similar Documents

Publication Publication Date Title
BR9407799A (pt) Composição de matéria método de tratamento e composição farmaceutica
BR9602542A (pt) Composto método para o tratamento de uma doença dependente da fosforilase de glicogénio composição farmacéutica e processo para a preparação de um composto
BR9503812A (pt) Composto composição farmacêutica utilização método de tratamento de um ser humano processo para a preparação de um composto
DE59710183D1 (de) Topische mittel zur prophylaxe oder behandlung bakterieller hautinfektionen
PL344535A1 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections
CA2189658A1 (en) Controlled-Release Dosage Forms of Azithromycin
TJ270B (en) 5,6-Dichlorobenzimidazole derivatives process for their preparation pharmaceutical composition and method of treatment or prophylaxis of virus infections
EP0758242A4 (en) COMPOSITIONS AND METHODS FOR TREATING CYTOMEGALOVIRUS (CMV) INFECTIONS
EE9800234A (et) Ravimeetod ja farmatseutiline kompositsioon
AU6411199A (en) Angiogenically effective unit dose of fgf and method of administering
BR9710250A (pt) Composto composição farmacêutica e processos para tratar uma infecção bacteriana em um paciente em necessidade de tal tratamento e para produzir um composto de bromotiacumicina
HUP0101901A3 (en) Pharmaceutical composition for combined therapeutic treatment of refractory depression and combined treating process
AU3681095A (en) Method and pharmaceutical composition for prevention and treatment of brain damage
EP0975654A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF CYTOMEGALOVIRUS INFECTIONS
BR9708864A (pt) Composto composição farmacêutica e processo para o tratamento ou a prevenção de uma infecção bacteriana em um paciente mamífero
BR9106377A (pt) Composicao e processo para o tratamento topico de tecido lesado ou enfermo
BR9510015A (pt) Composto composição farmacéutica e processo para o tratamento de doenças enfecciosas em terapia humana ou veterinária
ZA9510108B (en) Composition and method for prevention and treatment of HIV-1 infection
LV12172A (lv) Kompozicija organu kriokonservesanai um virusu un bakterialas infekcijas arstesanai
IL116925A (en) Combinations of compounds useful for treating HIV infections and pharmaceutical compositions comprising these combinations
GB2343844B (en) Composition and method for treatment of hypertrophic skin accumlations and their prevention
AU3607597A (en) Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases
FI965114A0 (fi) Farmaseuttinen koostumus virusinfektioiden sekä valinnaisesti tulehdusten estoon ja (tai) hoitoon sekä niiden hoitomenetelmä
BR9504119A (pt) Composto composiçao farmacêutica métodos para tratar uma infecçao bacteriana e uma infecçao micoplásmica
GB0127618D0 (en) "Composition and method for treatment of wounds"

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements